{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:11:00Z","timestamp":1776417060734,"version":"3.51.2"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.toxicon.2026.109090","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:25:46Z","timestamp":1775150746000},"page":"109090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Consensus computational immunogenicity modelling of botulinum neurotoxin serotypes: Cross-platform validation, uncertainty quantification, and relative risk assessment"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-8338","authenticated-orcid":false,"given":"Eqram","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4699-1579","authenticated-orcid":false,"given":"Golam","family":"Saklayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2082-2799","authenticated-orcid":false,"given":"Munim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5801-2105","authenticated-orcid":false,"given":"John H.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-626X","authenticated-orcid":false,"given":"William Richard","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2026.109090_bib1","first-page":"1","article-title":"Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.toxicon.2026.109090_bib2","doi-asserted-by":"crossref","DOI":"10.1021\/bi036278w","article-title":"Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212\u2192Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway","volume":"43","author":"Agarwal","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2026.109090_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008381","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2026.109090_bib4","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2026.109090_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-022-01710-x","article-title":"Introducing the FAIR principles for research software","volume":"9","author":"Barker","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.toxicon.2026.109090_bib6","article-title":"UniProt: the universal protein knowledgebase in 2025","volume":"53","author":"Bateman","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity associated with botulinum toxin treatment","volume":"11","author":"Bellows","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109090_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599840-000000000-00000","article-title":"Clinical relevance of botulinum toxin immunogenicity","volume":"26","author":"Benecke","year":"2012","journal-title":"BioDrugs"},{"key":"10.1016\/j.toxicon.2026.109090_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2013.06.026","article-title":"Crystal structures of botulinum neurotoxin dc in complex with its protein receptors synaptotagmin i and II","volume":"21","author":"Berntsson","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.toxicon.2026.109090_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-007-0004-5","article-title":"A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes","author":"Bhasin","year":"2007","journal-title":"J. Biosci."},{"key":"10.1016\/j.toxicon.2026.109090_bib11","doi-asserted-by":"crossref","DOI":"10.4161\/mabs.2.3.11782","article-title":"Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies","author":"Brennan","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.toxicon.2026.109090_bib12","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v076.i01","article-title":"Stan: a probabilistic programming language","volume":"76","author":"Carpenter","year":"2017","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.toxicon.2026.109090_bib13","series-title":"CPT: Pharmacometrics and Systems Pharmacology","article-title":"A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2 - model applications","author":"Chen","year":"2014"},{"key":"10.1016\/j.toxicon.2026.109090_bib14","series-title":"CPT: Pharmacometrics and Systems Pharmacology","article-title":"A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 1 - theoretical model","author":"Chen","year":"2014"},{"key":"10.1016\/j.toxicon.2026.109090_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/334395a0","article-title":"T-cell antigen receptor genes and T-cell recognition","author":"Davis","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109090_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2009.01.009","article-title":"Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics","author":"De Groot","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2007.08.007","article-title":"Immune recognition of botulinum neurotoxin B: Antibody-binding regions on the heavy chain of the toxin","volume":"45","author":"Dolimbek","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib19","series-title":"Protein Complex Prediction with AlphaFold-Multimer","author":"Evans","year":"2022"},{"key":"10.1016\/j.toxicon.2026.109090_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-015-9565-5","article-title":"Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis","volume":"29","author":"Fabbri","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib21","article-title":"Immunogenicity testing of therapeutic protein products \u2014 developing and validating assays for anti-drug antibody detection. FDA-2009-D-0539","year":"2019","journal-title":"Final"},{"issue":"D1","key":"10.1016\/j.toxicon.2026.109090_bib22","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI - a COmplex PAthway SImulator","volume":"22","author":"Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxicon.2026.109090_bib24","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.toxicon.2026.109090_bib25","series-title":"Getting to Good: Research Integrity in the Biomedical Sciences","article-title":"Why most published research findings are false","author":"Ioannidis","year":"2018"},{"key":"10.1016\/j.toxicon.2026.109090_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold - Supplementary information","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109090_bib27","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved Peptide\u2013MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00021","article-title":"Immunogenicity to biotherapeutics - the role of anti-drug immune complexes","author":"Krishna","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum Neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2026.109090_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1298473","article-title":"Immunogenicity of biotherapeutics: causes and association with posttranslational modifications","author":"Kuriakose","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.baga.2017.06.001","article-title":"Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies","volume":"9","author":"Lacroix-Desmazes","year":"2017","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.toxicon.2026.109090_bib32","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2026.109090_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.0c00613","article-title":"Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery","volume":"60","author":"Lee","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.toxicon.2026.109090_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr431","article-title":"Rosetta FlexPepDock web server - high resolution modeling of peptide-protein interactions","volume":"39","author":"London","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2012.05.010","article-title":"A theory of germinal center b cell selection, division, and exit","volume":"2","author":"Meyer-Hermann","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.toxicon.2026.109090_bib36","doi-asserted-by":"crossref","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.toxicon.2026.109090_bib37","article-title":"MHCflurry: open-source class I MHC binding affinity prediction","volume":"7","author":"O'Donnell","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.toxicon.2026.109090_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btt369","article-title":"Prediction of site-specific interactions in antibody-antigen complexes: the proABC method and server","volume":"29","author":"Olimpieri","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxicon.2026.109090_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib40","article-title":"Immunogenicity to botulinum toxin type A: a systematic review with meta-analysis across therapeutic indications","author":"Rahman","year":"2021","journal-title":"Aesthetic Surg. J."},{"key":"10.1016\/j.toxicon.2026.109090_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000008904","article-title":"Botulinum toxin type A immunogenicity across multiple indications: an overview systematic review","author":"Rahman","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.toxicon.2026.109090_bib43","article-title":"Predictive modelling of immunogenicity to botulinumtoxin A treatments for glabellar lines","author":"Rahman","year":"2024","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.toxicon.2026.109090_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108946","article-title":"Beyond structural divergence: multiscale computational immunogenicity modelling of botulinum neurotoxin E and cross-reactivity in botulinum neurotoxin A primed hosts","volume":"271","author":"Rahman","year":"2026","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109090_bib42","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/DSS.0000000000004293","article-title":"Immunogenicity of botulinum toxin A: insights","volume":"50","author":"Rahman","year":"2024","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2026.109090_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01732-21","article-title":"First-in-Human clinical trial to assess the safety, tolerability and pharmacokinetics of single doses of NTM-1633, a novel mixture of monoclonal antibodies against botulinum toxin E","volume":"66","author":"Raja","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2026.109090_bib46","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1800690115","article-title":"Developing a molecular dynamics force field for both folded and disordered protein states","volume":"115","author":"Robustelli","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.toxicon.2026.109090_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.toxicon.2026.109090_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110636","article-title":"Immunoinformatics and MD-simulation data suggest that Omicron spike epitopes are more interacting to IgG via better MHC recognition than Delta variant","volume":"123","author":"Sarkar","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.toxicon.2026.109090_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2018.05.008","article-title":"Evaluating and mitigating the immunogenicity of therapeutic proteins","author":"Sauna","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.toxicon.2026.109090_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109090_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","author":"Sette","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo\u2014distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxicon.2026.109090_bib55","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.toxicon.2026.109090_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btv123","article-title":"Automated benchmarking of peptide-MHC class i binding predictions","volume":"31","author":"Trolle","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxicon.2026.109090_bib57","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.toxicon.2026.109090_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/srep15776","article-title":"Antigenic sites on the H N domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin","volume":"5","author":"Vijayalakshmi Ayyar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2026.109090_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1092","article-title":"The Immune Epitope Database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinform."},{"key":"10.1016\/j.toxicon.2026.109090_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2026.109090_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.toxicon.2026.109090_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.toxicon.2026.109090_bib64","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.immunol.17.1.51","article-title":"Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses","author":"Yewdell","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2026.109090_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000005029","article-title":"Safety and efficacy of EB-001, a novel type E botulinum toxin, in subjects with glabellar frown lines: results of a phase 2, randomized, placebo-controlled, ascending-dose study","volume":"142","author":"Yoelin","year":"2018","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.toxicon.2026.109090_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gki524","article-title":"TM-align: a protein structure alignment algorithm based on the TM-score","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012600108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012600108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:16:37Z","timestamp":1776413797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101012600108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"alternative-id":["S004101012600108X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109090","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus computational immunogenicity modelling of botulinum neurotoxin serotypes: Cross-platform validation, uncertainty quantification, and relative risk assessment","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109090"}}